NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.

NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia. — المؤلف: Lopez-Millan, Belen — Leukemia 20191112

المؤلف
Lopez-Millan, Belen
النشر
Leukemia 20191112
الوصف
1557-1569 p.
الموضوعات
Animals؛ Antigens؛ Antineoplastic Combined Chemotherapy Protocols؛ Asparaginase؛ B-Lymphocytes؛ Dexamethasone؛ Drug Resistance, Neoplasm؛ Gene Rearrangement